论文部分内容阅读
上腔静脉综合征(svcs)是恶性淋巴瘤常见的急性并发症。作者1984年曾以大剂量阿糖胞苷(HDARAC)为主的联合化疗对一例重症恶性淋巴瘤骨髓侵犯取得满意疗效后,我们又相继治疗5例对“COP”方案无效的恶性淋巴瘤SVCS,并已取得了满意的近期疗效。现报告如下。 一、病例来源 5例svcs患者中,除一例因病理无法取材外,其余4例均由病理确诊为非何杰金氏恶性淋巴瘤。患者
Superior vena cava syndrome (svcs) is a common complication of malignant lymphoma. In 1984, a large dose of cytarabine (HDARAC) -based combination chemotherapy was used to treat one case of severe malignant lymphoma with satisfactory efficacy. We also treated 5 consecutive SVCS patients who were refractory to the “COP” regimen, And has achieved satisfactory near-term efficacy. The report is as follows. First, the source of the 5 cases of svcs patients, except for one case due to pathological can not be drawn, the remaining 4 cases were pathologically confirmed as non-Hodgkin’s lymphoma. patient